http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004050890-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06 |
filingDate | 2003-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2004050890-A1 |
titleOfInvention | Method for producing macrolide compounds |
abstract | The present invention provides a novel production method by biological conversion of a 12-membered macrolide compound 11107D substance having antitumor activity. The starting material is a 12-membered ring macrolide compound 11107B represented by the formula (I), and a Mortierella genus or a Streptomyces genus having the ability to convert the 11107D substance represented by the formula (II) Or a strain belonging to the family Micromonosporaceae (for example, Streptomyces sp. Strain AB-1704 (FERM BP-8551)), or a culture preparation thereof and the presence of oxygen in the presence of a starting material Is incubated, and the target 11107D substance is collected from the treatment solution. |
priorityDate | 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.